Advertisement

Document › Details
Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford.
![]() |
Organisation | Refeyn Ltd. |
Group | Refeyn (Group) | |
Organisation 2 | Sartorius (Group) | |
![]() |
Product | mass photometry technology |
Product 2 | laboratory equipment and instruments | |
![]() |
Person | Coats, Fiona (Sartorius 202404 Head of Marketing at Lab Products + Services division) |
Person 2 | Ahmed, J. Omee (Alto Marketing 201512) | |
Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024. Forming part of Refeyn’s executive team, Fiona will bring with her a wealth of experience from over 25 years in the biotechnology sector. Her extensive background in science, combined with a proven track record of driving growth and innovation, positions her as a respected leader in the life science research market.
Educated in the UK, Fiona holds a Ph.D. in Physiology/Pharmacology and a B.Sc. in Pharmacology, and has successfully leveraged her scientific insights to excel in strategic marketing and drive business expansion. Her career highlights include spearheading revenue growth, crafting cutting-edge go-to-market strategies, and overseeing product management within the competitive life science research arena.
Fiona's professional journey includes pivotal roles at Biosource International, Meso Scale Diagnostics, ThermoFisher Scientific and more recently at Sartorius, where she has consistently excelled in building brands and expanding market presence. She has managed global teams and budgets with a focus on transformative returns through innovative marketing strategies targeting attractive growth segments. As she takes on the role of Chief Marketing Officer, Fiona's expertise is expected to drive the company's growth and solidify its market position. Her dynamic and informed marketing leadership is set to propel the company towards a future of sustained success.
To find out more about Refeyn and mass photometry, please visit: https://www.refeyn.com
- ENDS -
This release is available online at: https://www.refeyn.com/post/refeyn-appoints-new-chief-marketing-officer
Editor’s notes
About Refeyn www.refeyn.com
Refeyn Ltd. specializes in the development, production, and distribution of mass photometry technologies for industry and academia. Mass photometry and macro mass photometry are unique bioanalytical technologies pioneered by Refeyn. By quantifying light scattering from particles in solution, mass photometry enables the measurement of molecular mass at the single-particle level while macro mass photometry enables simultaneous measurement of viral vector size and contrast (a proxy for mass).
Spun out of Oxford University in 2018, the company aims to make its technology accessible to all in the scientific community, enabling users to achieve new and better outcomes. Refeyn has been recognized for its unique approach to biomolecular analysis through multiple awards, including the Royal Society of Chemistry Emerging Technologies Competition. Applications of mass photometry include: Characterization of samples of biomolecules and viral vectors, and analysis of protein oligomerization, biomolecular interactions, and macromolecular assemblies. Utilizing the novel technologies of mass photometry and macro mass photometry, Refeyn’s products are capable of accurate analysis of single particles in solution, in their native state, and without the need for labels, opening up new possibilities for bioanalytics.
Code 2402REF
Contacts:
Alto Marketing:
Omee Ahmed – Senior Manager, Digital & Science Communications; E: [email protected]; T: +44 (0)2392 004 596
Refeyn:
Catie Lichten – Scientific Communications Manager; E: [email protected]; T: +44 (0)1865 800 175
Record changed: 2024-06-05 |
Advertisement

More documents for Refeyn (Group)
- [1] Refeyn Ltd.. (11/30/23). "Press Release: Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors". Oxford....
- [2] Refeyn Ltd.. (10/17/23). "Press Release: Refeyn Expands the Analytical Possibilities for High Concentration Samples by MassFluidix HC". Oxford....
- [3] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
- [4] Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim....
- [5] Refeyn Ltd.. (8/15/23). "Press Release: Refeyn Expands into AAV-based Gene Therapy Manufacturing with GMP Software". Oxford....
- [6] Refeyn Ltd.. (5/31/23). "Press Release: Refeyn Announces Vice President of Sales and Marketing"....
- [7] Refeyn Ltd.. (4/11/23). "Press Release: Refeyn Closes Series B Funding Round". Oxford....
- [8] Refeyn Ltd.. (2/14/23). "Press Release: Refeyn Launches SamuxMP Auto for Automated AAV Capsid Analysis". Oxford....
- [9] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
- [10] Refeyn Ltd.. (2/9/22). "Press Release: Refeyn TwoMP Auto – Automated Protein Characterization at Single-molecule Level in Solution". Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top